Patents by Inventor Pele Choi Sing Chong

Pele Choi Sing Chong has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ADJUVANTS
    Publication number: 20100166785
    Abstract: Disclosed are lipopeptides or lipoproteins, related compositions, and related methods.
    Type: Application
    Filed: February 9, 2010
    Publication date: July 1, 2010
    Applicant: National Health Research Institutes
    Inventors: Shih-Jen Liu, Hsueh-Hung Liu, Chih-Hsiang Leng, Hsin-Wei Chen, Yan Chak Kwok, Pele Choi-Sing Chong
  • Lipidating Sequences and Use thereof for Producing Lipidated Proteins in E. Coli
    Publication number: 20090221499
    Abstract: Production in E. coli of a lipidated fusion protein containing a lipidating sequence derived from Ag473 and a target polypeptide.
    Type: Application
    Filed: December 10, 2008
    Publication date: September 3, 2009
    Applicant: National Health Research Institutes
    Inventors: Chih-Hsiang Leng, Hsin-Wei Chen, Pele Choi-Sing Chong, Shih-Jen Liu
  • Production of Lipidated Proteins In E. coli
    Publication number: 20090176273
    Abstract: Production of a lipidated protein in an E. coli strain adapted to membrane protein expression.
    Type: Application
    Filed: December 5, 2008
    Publication date: July 9, 2009
    Applicant: National Health Research Institutes
    Inventors: Chih-Hsiang Leng, Shih-Jen Liu, Hsin-Wei Chen, Pele Choi-Sing Chong
  • IMMUNOPEPTIDES OF HPV E6 AND E7 PROTEINS
    Publication number: 20090117123
    Abstract: An immunopeptide containing a cytotoxic T lymphocyte epitope derived from HPV E6 or HPV E7 protein. The immunopeptide can be used as a component of a vaccine for enhancing immune responses against HPV or treating HPV-associated diseases. Also within the scope of this invention are a nucleic acid encoding the immunopeptide and an antibody specific to the CTL epitope.
    Type: Application
    Filed: September 23, 2008
    Publication date: May 7, 2009
    Applicant: National Health Research Institutes
    Inventors: Shih-Jen Liu, Hsin-Wei Chen, Pele Choi-Sing Chong
  • VERO CELL-BASED INFLUENZA VIRUS STRAINS AND VACCINES
    Publication number: 20090074804
    Abstract: The present invention relates to isolated influenza virus strains suitable for increased vaccine production for mammals. The influenza virus strains contain at least one modified influenza protein that results in increased production of the influenza virus from a mammalian host cell, such as a vero cell. The present invention also relates to the vaccines produced from the influenza virus strains. The present invention further relates to isolated modified influenza proteins and isolated nucleic acid molecules that encode for the modified influenza proteins.
    Type: Application
    Filed: September 5, 2008
    Publication date: March 19, 2009
    Applicant: National Health Research Institute (an institution of Taiwan, R.O.C.)
    Inventors: Min-Shi Lee, Yu Shuan Chen, Yu-Fen Tseng, Pele Choi-Sing Chong
  • Dengue virus peptide vaccine and methods of preparing and using the same
    Publication number: 20090074781
    Abstract: A consensus peptide sequence designed for domain III of the envelope proteins of four serotypes of dengue virus and used in a vaccine against multiple serotypes of dengue virus is disclosed. The vaccine is able to elicit cross-neutralization antibody responses against multiple serotypes of dengue virus.
    Type: Application
    Filed: June 4, 2008
    Publication date: March 19, 2009
    Applicant: National Health Research Institute
    Inventors: Hsin-Wei Chen, Chih-Hsiang Leng, Pele Choi-Sing Chong
  • Receptor binding polypeptides
    Patent number: 7491397
    Abstract: Isolated polypeptides containing fragments of SARS CoV S protein and functional equivalents thereof. Also disclosed are isolated nucleic acids encoding the polypeptides, related expression vectors, related host cells, related antibodies, and related compositions. Methods of producing the polypeptide, diagnosing infection with a coronavirus, and identifying a test compound for treating infection with a coronavirus are also disclosed.
    Type: Grant
    Filed: January 10, 2005
    Date of Patent: February 17, 2009
    Assignee: National Health Research Institutes
    Inventors: Pele Choi Sing Chong, Shie-Liang Hsieh
  • Receptor Binding Polypeptides
    Publication number: 20090022735
    Abstract: Isolated polypeptides containing fragments of SARS CoV S protein and functional equivalents thereof. Also disclosed are isolated nucleic acids encoding the polypeptides, related expression vectors, related host cells, related antibodies, and related compositions. Methods of producing the polypeptide, diagnosing infection with a coronavirus, and identifying a test compound for treating infection with a coronavirus are also disclosed.
    Type: Application
    Filed: July 28, 2008
    Publication date: January 22, 2009
    Applicant: National Health Research Institutes
    Inventors: Pele Choi Sing Chong, Shie-Liang Hsieh
  • RECEPTOR BINDING POLYPEPTIDES
    Publication number: 20080213284
    Abstract: Isolated polypeptides containing fragments of SARS CoV S protein and functional equivalents thereof. Also disclosed are isolated nucleic acids encoding the polypeptides, related expression vectors, related host cells, related antibodies, and related compositions. Methods of producing the polypeptide, diagnosing infection with a coronavirus, and identifying a test compound for treating infection with a coronavirus are also disclosed.
    Type: Application
    Filed: January 10, 2005
    Publication date: September 4, 2008
    Inventors: Pele Choi Sing Chong, Shie-Liang Hsieh